Comparison of E test and agar dilution methods for determining antibiotic susceptibilities of anaerobic bacteria and viridans streptococci isolated from blood

Anaerobe

Volumn 4, Issue 1, 1998, Pages 29-33

  Hall, G ^a   Heimdahl, A ^a   Nord, C E ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Agar dilution; Antibiotic susceptibility; Bacteremia; Dental extraction; E test

Indexed keywords

AGAR; ANTIBIOTIC AGENT; CEFACLOR; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN V;

AEROBIC BACTERIUM; ALPHA HEMOLYTIC STREPTOCOCCUS; ANAEROBIC BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD; COMPARATIVE STUDY; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TOOTH EXTRACTION;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS;

EID: 0031981576     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1006/anae.1997.0138     Document Type: Article

References (23)

1. Heimdahl A., Hall G., Hedberg M., Sandberg H., Söder P. Ö., Tunér K., Nord C. E. Detection and quantitation by lysis-filtration of bacteremia after different oral surgical procedures. J Clin Microbiol. 28:1990;2205-2209.
2. Hall G., Heimdahl A., Hedström S. Å., Nord C. E. Prophylactic administration of penicillins does not reduce the incidence of postextraction bacteremia. Clin Infect Dis. 17:1993;188-194.
3. Young S. E.J. Aetiology and epidemiology of infective endocarditis in England and Wales. J Antimicrob Chemother. 20:1987;7-14.
4. Bochud P. Y., Calandra T., Francioli P. Bacteremia due to viridans streptococci in neutropenic patients: a review. Am J Med. 97:1994;256-264.
5. Alcaide F., Linares J., Pallares R., Carratala J., Benitez M. A., Gudiol F., Martin R. In vitro activities of 11 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother. 39:1995;2243-2247.
6. Felner J. M., Dowell V. R. Anaerobic bacterial endocarditis. New Engl J Med. 283:1970;1188-1192.
7. Sussman J. I., Goldberg E. J., Kaplan M. H., Pizzarello R. A. Clinical manifestations and therapy of lactobacillus endocarditis: report of a case and review of the literature. Rev Inf Dis. 8:1986;771-776.
8. Baquero F., Fernandéz J., Dronda F., Erice A., Pérez de Oteiza J., Reguera J. A., Reig M. Pathogenesis and immune mechanisms of anaerobic infections. Rev Infect Dis. 12:1990;157-160.
9. Leport C., Horstkotte D., Burckhardt D. Antibiotic prophylaxis for endocarditis from an international group of experts towards a European consensus. Eur Heart J. 16:1995;126-131.
10. Miller L. A., Rittenhouse S. F., Utrup L. J., Poupard J. A. Comparison of three methods for determination of a single MIC of an antimicrobial agent. J Clin Microbiol. 32:1994;1373-1375.
11. Baker C. N., Stocker S. A., Culver D. H., Thornsberry C. Comparison of the E test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol. 29:1991;533-538.
12. Murray P. R., Pfaller M. A., Tenover F. C., Yolken R. H. Manual of Clinical Microbiology. 1995;American Society for Microbiology, Washington.
13. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. 1993;Approved Standard M11-A3, Villanova.
14. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. 1990;Approved Standard M7-A2, Villanova.
15. Performance Standards for Antimicrobial Susceptibility Testing. 1992;Fourth Informational Supplement: M100-S4, Villanova.
16. Citron D. M., Ostovari M. I., Karlsson A., Goldstein E. J.C. Evaluation of the E test for susceptibility testing of anaerobic bacteria. J Clin Microbiol. 29:1991;2197-2203.
17. Neu H. C., Fu K. P. Cefaclor: in vitro spectrum of activity and beta-lactamase stability. Antimicrob Agents Chemother. 13:1978;584-588.
18. Preston D. A. Summary of laboratory studies on the antibacterial activity of cefaclor. Postgrad Med J. 55:1979;22-29.
19. Pajukanta R., Asikainen S., Forsblom B., Piekkola M., Jousimies-Somer H. Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis. Oral Microbiol Immunol. 9:1994;123-125.
20. Meyers B. R., Hirschman S. Z. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin. J Clin Pharmacol. 18:1963;85-90.
21. Glynne A., Goulbourn R. A., Ryden R. A human pharmacology study of cefaclor. J Antimicrob Chemother. 4:1978;343-348.
22. Fass R. J., Prior R. B. Comparative in vitro activities of oral cephalosporins and competitive antibiotics against recent clinical isolates. Curr Therap Res. 24:1978;352-365.
23. Hall G., Heimdahl A., Nord C. E. Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction. Eur J Clin Microbiol Infect Dis. 15:1996;646-649.